MENSNasdaq

Jyong Biotech Ltd.

Healthcare·Healthcare·New Taipei City, Taiwan

Jyong Biotech Ltd. (MENS): 1 pipeline candidate · ~5 mo cash runway. Updated within the last hour.

4.9/10

BioSniper Score

3-factor signal · derived from public data

Cash Runway1.5

5.4 months

Financial Health10.0

D/E -1.83 · 0% dilution

Pipeline MaturityN/A

N/A

Pipeline Breadth3.3

1 candidate

Catalyst MomentumN/A

N/A

Insider SignalN/A

N/A

A transparent, data-derived signal for Jyong Biotech Ltd.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.

Key Financials

Market Cap

$121.6M

Cash

$1.2M

Quarterly Burn

$3.0M

Runway

5.4 mo

Revenue

Cash Runway vs Catalysts

Tracked catalysts land within the current projected cash runway.

Cash ends ~Nov 2026
Today~7 mo out
Catalyst within runway

Pipeline (1 candidate)

DrugPhase
patient examination gloves

Institutional Holdings

Source: SEC Form 13F · as of Mar 2026

Institutional holders

12

Total value held

$775K

HolderSharesValue
blackrock, inc.258,760$556K
geode capital management, llc64,232$138K
millennium management llc14,590$31K
morgan stanley6,301$14K
barclays plc5,189$11K
mirae asset global investments co., ltd.3,872$8K
citigroup inc2,787$6K
bnp paribas financial markets1,881$4K
gf fund management co. ltd.1,677$4K
bell investment advisors, inc473$1K

Showing top 10 of 12 institutional holders of Jyong Biotech Ltd.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.

·CEO: Ms. Fu-Feng Kuo

Frequently asked questions

How many drug candidates are in Jyong Biotech Ltd.'s pipeline?

Jyong Biotech Ltd. (MENS) has 1 pipeline candidate tracked by BioSniper across SEC filings and clinical trial registrations.

What is Jyong Biotech Ltd.'s cash runway?

Based on its most recent reported cash balance and quarterly burn rate, Jyong Biotech Ltd. has approximately 5.4 months of cash runway.

What is Jyong Biotech Ltd.'s market capitalization?

Jyong Biotech Ltd.'s market capitalization is approximately $121.6M.

Who is the CEO of Jyong Biotech Ltd.?

Ms. Fu-Feng Kuo is the chief executive officer of Jyong Biotech Ltd. (MENS).

Get the full picture on Jyong Biotech Ltd.

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.